Identification of a novel splice variant for mouse and human interleukin-5.
Alternative splicing
Biomolecules
Cytokine
Gene expression
Genetics
Immunology
Lymphocytes
Protein expression
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
30
04
2019
revised:
25
07
2019
accepted:
10
03
2020
entrez:
27
3
2020
pubmed:
27
3
2020
medline:
27
3
2020
Statut:
epublish
Résumé
Expression of interleukins and their receptors is often regulated by alternative splicing. Alternative isoform of IL-5 receptor α-chain is well studied; however, no data on functional alternative splice variants of IL-5 has been reported up today. In the present study, we describe a novel splice variant for the mouse and human IL-5. The new form was found during analysis of PCR-products amplified from different mouse lymphoid tissues with a pair of primers designed to clone full-length mIL-5 ORF. A single short isoform of mIL-5 was detected along with the canonical full-length mRNA in ConA-stimulated lymphoid cells isolated from spleen, thymus, lymph nodes and blood. It was 30-40 nt shorter, and less abundant than classical form. The sequence analysis of an additional form of mIL-5 revealed that it lacks exon-2 (δ2). Using RT-PCR with the splice-specific primers we obtained an additional evidence for δ2 form expression. To verify whether mIL-5δ2 transcript is translated into protein, the coding sequences corresponding to full and δ2 forms of mIL-5 were cloned into an expression plasmid. After transfection into the human 293T cell line, we found that the short form of mIL-5 protein is expressed in cells and secreted into the supernatant, but at the reduced level than that detected for full isoform of mIL-5. Fluorescence microscopy examination revealed a partial translocation of mIL-5δ2 into cytoplasm, whereas mIL-5 resided mostly within endoplasmic reticulum. This can explain why the level of δ2 protein expression was reduced. Using a similar set of experimental approaches, we received the evidence that the human IL-5 mRNA has the δ2 splice form (hIL-5δ2) as well. It can be firmly detected by RT-PCR in PHA-activated mononuclear cells isolated from peripheral blood of healthy persons or patients with asthma. Altogether, our results showed that the human and mouse IL-5 have an alternative mRNA splice isoform, which loses exon-2, but nevertheless is expressed at protein level. However, more comprehensive studies will be required for evaluation of IL-5δ2 expression, regulation, biological function and clinical significance.
Identifiants
pubmed: 32211550
doi: 10.1016/j.heliyon.2020.e03586
pii: S2405-8440(20)30431-X
pii: e03586
pmc: PMC7082524
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e03586Informations de copyright
© 2020 The Author(s).
Références
Cytokine. 2012 Apr;58(1):20-6
pubmed: 22249152
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7388-92
pubmed: 2823259
Growth Factors. 1988;1(1):51-7
pubmed: 3078564
Am J Respir Crit Care Med. 2001 Sep 15;164(6):1016-8
pubmed: 11587989
J Leukoc Biol. 2011 May;89(5):763-70
pubmed: 21285395
J Biol Chem. 1987 Dec 5;262(34):16580-4
pubmed: 2824500
Protein Sci. 2012 Jun;21(6):850-64
pubmed: 22528658
J Exp Med. 1985 Jul 1;162(1):60-74
pubmed: 3925072
J Exp Med. 1996 Jan 1;183(1):195-201
pubmed: 8551223
Nature. 1993 May 13;363(6425):172-6
pubmed: 8483502
Life Sci. 1997;61(12):1105-12
pubmed: 9315502
J Biol Chem. 2008 Oct 24;283(43):28860-72
pubmed: 18708357
Nat Chem Biol. 2009 Nov;5(11):815-22
pubmed: 19841631
EMBO J. 1991 May;10(5):1193-9
pubmed: 2022187
J Allergy Clin Immunol. 1999 Nov;104(5):978-82
pubmed: 10550742
Am J Respir Crit Care Med. 1995 May;151(5):1346-53
pubmed: 7537586
Cell Immunol. 1999 Feb 1;191(2):161-7
pubmed: 9973539
Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:75-91
pubmed: 9698919
Front Med (Lausanne). 2017 Aug 31;4:135
pubmed: 28913336
J Immunol. 1996 Jan 15;156(2):435-41
pubmed: 8543791
Blood. 1992 Jun 15;79(12):3101-9
pubmed: 1596561
Nihon Rinsho. 1995 Mar;53 Su Pt 2:786-9
pubmed: 8753359
J Exp Med. 1982 Mar 1;155(3):914-23
pubmed: 6977612
Exp Hematol. 1991 Oct;19(9):882-7
pubmed: 1893964
J Proteome Res. 2003 May-Jun;2(3):273-81
pubmed: 12814267
J Allergy Clin Immunol. 1993 Aug;92(2):313-24
pubmed: 8349942
Allergy. 1993;48(17 Suppl):98-106; discussion 110-1
pubmed: 8109721
Cytokine. 2017 Nov;99:154-162
pubmed: 28917204
PLoS Pathog. 2010 Feb 26;6(2):e1000788
pubmed: 20195464
EMBO J. 1990 Dec;9(13):4367-74
pubmed: 2265612
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7041-5
pubmed: 1495999
Nucleic Acids Res. 1986 Nov 25;14(22):9149-58
pubmed: 3024129
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6629-33
pubmed: 3498940
Nature. 1986 Nov 6-12;324(6092):70-3
pubmed: 3024009
Expert Rev Clin Immunol. 2016 Sep;12(9):903-5
pubmed: 27450970
Nat New Biol. 1972 May 3;237(70):15-7
pubmed: 4503682
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2311-5
pubmed: 2784567